As the use of GLP-1 agonists medications (e.g., Ozempic, Wegovy) rises, so do concerns about their prescription to individuals with active, historical, or at-risk of eating disorders. This webinar supports ED practitioners in navigating complex, relational conversations with clients exploring or already using these medications. This is not a webinar on pharmacology or pathophysiology of GLP-1 agonists. Rather, it focuses on relational, ethical, and consent-based approaches to client care.